GlassScriptPhysician profile
Daphne Sarah Horowitz
NPI 1841357183
$2,937.75
in general payments reported to CMS, 2019-2025
20 companies · $511 in 2025
The $511 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2021: $302 · 2022: $105 · 2023: $594 · 2024: $762 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $462.70 | 2019-2025 | Bexsero, Rotarix, Penmenvy |
| Astrazeneca Pharmaceuticals LP | $352.35 | 2019-2024 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $330.22 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Genzyme Corporation | $274.03 | 2023-2024 | |
| Tris Pharma INC | $260.25 | 2019-2023 | Quillichew Er, Quillivant, Dyanavel Xr |
| Sanofi Pasteur INC. | $245.17 | 2021-2024 | |
| Pfizer INC. | $161.16 | 2023-2025 | |
| Mirum Pharmaceuticals, INC. | $149.24 | 2024 | Livmarli |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | Dupixent |
| Novo Nordisk INC | $116.98 | 2024 | Wegovy |
| Cranial Technologies, INC | $113.87 | 2019-2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $106.88 | 2023-2025 | Ycanth |
| Seqirus USA INC | $60.10 | 2024-2025 | Flucelvax |
| Sobi, INC | $38.46 | 2021-2023 | |
| Ultragenyx Pharmaceutical INC. | $36.94 | 2022-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $24.25 | 2025 | Zelsuvmi |
| Medline Industries LP | $23.07 | 2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.30 | 2025 | Clear+Brilliant |
| Alk-Abello, INC | $18.79 | 2024 | Grastek, Odactra, Ragwitek |
| Abbott Laboratories | $16.99 | 2025 | Id Now Instrument |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.